Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New recovery protocol aims to get stomach cancer patients home sooner

NCT ID NCT06984952

Symptom relief Sponsor: Seoul National University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether a special recovery plan (ERAS) helps people recover faster after minimally invasive stomach cancer surgery. The plan includes education before surgery, shorter fasting, early eating and walking, and less use of strong painkillers. Researchers will track how many patients meet discharge criteria, such as eating soft food and walking 600 meters, compared to standard care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Enhanced Recovery After Surgery (ERAS) protocol
What this could lead to
If it works, this could lead to a standard care plan that helps patients leave the hospital sooner after stomach cancer surgery.
What could go wrong
This is a relatively small trial (308 people) testing a care process, not a new drug. The results may not apply to all hospitals or patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 308 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2025

Expected to finish

Mar 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged ≥19 years scheduled to undergo elective laparoscopic or robotic gastrectomy for gastric cancer * American Society of Anesthesiologists physical status classification I to III * Ability to provide written informed consent, demonstrate understanding of the study protocol, and complete patient-reported outcome measures appropriately Exclusion Criteria: * Requirement for resection of organs other than the stomach during surgery (except for cholecystectomy) * History of upper abdominal surgery (except for cholecystectomy) * Known hypersensitivity to fentanyl, ropivacaine, acetaminophen, or non-steroidal anti-inflammatory drugs * Determined by the investigator or study personnel to be otherwise unsuitable for participation in the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Enhanced recovery after surgery are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

gastric cancer gastric neoplasm Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Enhanced recovery after surgery Gastrectomy for gastric cancer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    10 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Ajou University School of Medicine

    NOT_YET_RECRUITING

    Suwon, South Korea

  • Chungnam National University Hospital

    NOT_YET_RECRUITING

    Daejeon, South Korea

  • Dongsan Hospital, Keimyung University School of Medicine

    RECRUITING

    Daegu, South Korea

  • National Cancer Center

    NOT_YET_RECRUITING

    Goyang, South Korea

  • Pusan National University Hospital

    NOT_YET_RECRUITING

    Busan, South Korea

  • SMG-SNU Boramae Medical Center,

    NOT_YET_RECRUITING

    Seoul, South Korea

  • Seoul National University Bundang Hospital

    NOT_YET_RECRUITING

    Seongnam, South Korea

  • Seoul National University Hospital

    RECRUITING

    Seoul, South Korea

  • Seoul St. Mary's Hospital

    NOT_YET_RECRUITING

    Seoul, South Korea

  • Severance hospital

    NOT_YET_RECRUITING

    Seoul, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.